Friday, 12 October 2018

Nanoparticles show promise in treatment for triple-negative breast cancer


Researchers have found that nanoparticle-encapsulated doxorubicin is promising in the treatment of triple-negative breast cancer. Doxorubicin is a well-known anthracycline drug class used primarily in combination chemotherapy

https://goo.gl/gN8E4p



By at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Nanotechnology Events 2019: Speaker Opportunity Available

Be a  #Speaker  at the 4th International Conference on Nanomedicine and Nanotechnology  (#Nanotechnolog y 2019) to be held on May 20-21,...

  • Speaker slots available
    #Book your #speaker slot now at #Nanomedicine 2018 Gather at #Rome, #Italy during August 20-21, 2018 to #explore your #research Click he...
  • Nanomedicine 2018
    About Conference Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals est...
  • Nanotechnology Events 2019: Speaker Opportunity Available
    Be a  #Speaker  at the 4th International Conference on Nanomedicine and Nanotechnology  (#Nanotechnolog y 2019) to be held on May 20-21,...